세계의 Cardiogenomics 시장 보고서(2025년)

Cardiogenomics is the study of how an individual's genetic variations affect the risk, onset, and progression of cardiovascular diseases. It is essential for enabling personalized prevention, precise diagnosis, and targeted treatment strategies to improve heart health outcomes.

The primary product types in cardiogenomics are testing kits, reagents, instruments, software, and services. Testing kits are packaged tools and consumables designed to conduct specific genetic tests. The technologies used include next-generation sequencing, polymerase chain reaction, microarrays, and others. These products are applied in areas such as congenital heart diseases, cardiomyopathies, arrhythmias, coronary artery disease, and others, and serve end-users including hospitals and clinics, diagnostic laboratories, research institutions, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The cardiogenomics market research report is one of a series of new reports from The Business Research Company that provides cardiogenomics market statistics, including cardiogenomics industry global market size, regional shares, competitors with a cardiogenomics market share, detailed cardiogenomics market segments, market trends and opportunities, and any further data you may need to thrive in the cardiogenomics industry. This cardiogenomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiogenomics market size has grown rapidly in recent years. It will grow from $1.50 billion in 2024 to $1.74 billion in 2025 at a compound annual growth rate (CAGR) of 15.8%. The growth in the historic period can be attributed to the expanding use of polygenic risk scores in cardiac care, increasing investments in genomic research and development, higher government and private funding for cardiovascular genomics, growing interest in preventive cardiology informed by genetic insights, and greater focus on population-scale genomic studies.

The cardiogenomics market size is expected to see rapid growth in the next few years. It will grow to $3.10 billion in 2029 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to rising demand for personalized medicine, increasing prevalence of cardiovascular diseases, higher adoption of genetic testing for early risk detection, greater awareness of precision medicine approaches, and expanded availability of direct-to-consumer genetic testing services. Key trends in the forecast period include technological innovations in sequencing enabling precise cardiac analysis, integration of genomics with health records supporting personalized care, improvements in polygenic risk scoring for early disease prediction, advancements in bioinformatics accelerating genomic data interpretation, and platforms supporting high-throughput genetic testing.

Rising demand for personalized medicine is expected to drive growth in the cardiogenomics market. Personalized medicine customizes prevention, diagnosis, and treatment according to an individual's genetic makeup, environment, and lifestyle. Advances in genomics have increased personalized medicine by providing greater insight into genetic variations, enabling more precise and targeted treatments that enhance patient outcomes and reduce trial-and-error approaches. Cardiogenomics supports personalized medicine by using genetic information to tailor the prevention, diagnosis, and treatment of cardiovascular diseases to each person's unique genetic profile. For example, in February 2024, the Personalized Medicine Coalition, a US nonprofit, reported that the FDA approved 16 new personalized therapies for rare diseases in 2023, up from six in 2022. The 2023 approvals also included seven cancer drugs and three treatments for other conditions. This rising demand for personalized medicine is fueling the growth of the cardiogenomics market.

Key companies in the cardiogenomics market are developing innovative solutions such as oncogenomics to improve early detection and personalized treatment of cancers related to cardiovascular health. Oncogenomics studies cancer-associated genes and mutations to better understand cancer progression and develop targeted therapies and personalized treatment options. For instance, in April 2025, Fortis Healthcare Ltd., an India-based healthcare provider, opened the Fortis Institute of Genomic Medicine to advance genetic research and personalized care. The institute enhances patient treatment by enabling early disease detection, accurate diagnosis, and personalized therapies across fields including oncology, cardiology, and neurology. It supports targeted treatments, improves patient outcomes, and promotes preventive care for hereditary conditions. The institute's goal is to advance precision medicine through a multidisciplinary team and innovative technologies, making healthcare more tailored and effective for Indian patients.

In March 2025, Tempus AI Inc., a US-based technology firm, acquired Ambry Genetics Corporation for an undisclosed sum. This acquisition aims to enhance Tempus AI's precision medicine offerings by combining genetic testing with AI-driven data analysis to improve patient outcomes and provide personalized care across multiple diseases. Ambry Genetics Corporation is a US genetic testing and precision medicine company that provides cardiogenomics services.

Major players in the cardiogenomics market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings (Labcorp), Quest Diagnostics Incorporated, Illumina Inc., QIAGEN N.V., Myriad Genetics Inc., ARUP Laboratories, BGI Genomics Co. Ltd., Invitae Corporation, GeneDx Inc., Helix OpCo LLC, SOPHiA GENETICS SA, Baylor Genetics, Blueprint Genetics, Novogenia GmbH, Veritas Genetics, Dante Genomics, Gene by Gene Ltd., GENinCode Plc., UAB Cardiogenomics Clinic

North America was the largest region in the cardiogenomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cardiogenomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cardiogenomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cardiogenomics market consists of revenues earned by entities by providing services such as genetic testing and screening, risk assessment and prediction, and counseling services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiogenomics market also includes sales of cardiogenomic testing panels, genetic testing panels, and direct-to-consumer (DTC) genetic tests. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiogenomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiogenomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiogenomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiogenomics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Testing Kits; Reagents; Instruments; Software; Services
• 2) By Technology: Next-Generation Sequencing; Polymerase Chain Reaction; Microarray; Other Technologies
• 3) By Application: Congenital Heart Diseases; Cardiomyopathies; Arrhythmias; Coronary Artery Disease; OtherApplications
• 4) By End-User: Hospitals And Clinics; Diagnostic Laboratories; Research Institutes; Other End Users
• Subsegments:
• 1) By Testing Kits: PCR (Polymerase Chain Reaction) kits; Microarray kits; NGS (Next Generation Sequencing) kits
• 2) By Reagents: Enzymes; Probes; Buffers
• 3) By Instruments: Sequencers; Genotyping instruments; Microarray scanners
• 4) By Software: Data analysis software; Reporting platforms; Bioinformatics tools
• 5) By Services: Genetic testing services; Counseling services; Data analysis services
• Companies Mentioned: Thermo Fisher Scientific Inc.; Laboratory Corporation of America Holdings (Labcorp); Quest Diagnostics Incorporated; Illumina Inc.; QIAGEN N.V.; Myriad Genetics Inc.; ARUP Laboratories; BGI Genomics Co. Ltd.; Invitae Corporation; GeneDx Inc.; Helix OpCo LLC; SOPHiA GENETICS SA; Baylor Genetics; Blueprint Genetics; Novogenia GmbH; Veritas Genetics; Dante Genomics; Gene by Gene Ltd.; GENinCode Plc.; UAB Cardiogenomics Clinic
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cardiogenomics Market Characteristics

3. Cardiogenomics Market Trends And Strategies

4. Cardiogenomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cardiogenomics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cardiogenomics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cardiogenomics Market Growth Rate Analysis
• 5.4. Global Cardiogenomics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cardiogenomics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cardiogenomics Total Addressable Market (TAM)

6. Cardiogenomics Market Segmentation

• 6.1. Global Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Testing Kits
• Reagents
• Instruments
• Software
• Services
• 6.2. Global Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Next-Generation Sequencing
• Polymerase Chain Reaction
• Microarray
• Other Technologies
• 6.3. Global Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Congenital Heart Diseases
• Cardiomyopathies
• Arrhythmias
• Coronary Artery Disease
• OtherApplications
• 6.4. Global Cardiogenomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Diagnostic Laboratories
• Research Institutes
• Other End Users
• 6.5. Global Cardiogenomics Market, Sub-Segmentation Of Testing Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pcr (Polymerase Chain Reaction) Kits
• Microarray Kits
• Ngs (Next Generation Sequencing) Kits
• 6.6. Global Cardiogenomics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enzymes
• Probes
• Buffers
• 6.7. Global Cardiogenomics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sequencers
• Genotyping Instruments
• Microarray Scanners
• 6.8. Global Cardiogenomics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Data Analysis Software
• Reporting Platforms
• Bioinformatics Tools
• 6.9. Global Cardiogenomics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genetic Testing Services
• Counseling Services
• Data Analysis Services

7. Cardiogenomics Market Regional And Country Analysis

• 7.1. Global Cardiogenomics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cardiogenomics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cardiogenomics Market

• 8.1. Asia-Pacific Cardiogenomics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cardiogenomics Market

• 9.1. China Cardiogenomics Market Overview
• 9.2. China Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cardiogenomics Market

• 10.1. India Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cardiogenomics Market

• 11.1. Japan Cardiogenomics Market Overview
• 11.2. Japan Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cardiogenomics Market

• 12.1. Australia Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cardiogenomics Market

• 13.1. Indonesia Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cardiogenomics Market

• 14.1. South Korea Cardiogenomics Market Overview
• 14.2. South Korea Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cardiogenomics Market

• 15.1. Western Europe Cardiogenomics Market Overview
• 15.2. Western Europe Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cardiogenomics Market

• 16.1. UK Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cardiogenomics Market

• 17.1. Germany Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cardiogenomics Market

• 18.1. France Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cardiogenomics Market

• 19.1. Italy Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cardiogenomics Market

• 20.1. Spain Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cardiogenomics Market

• 21.1. Eastern Europe Cardiogenomics Market Overview
• 21.2. Eastern Europe Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cardiogenomics Market

• 22.1. Russia Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cardiogenomics Market

• 23.1. North America Cardiogenomics Market Overview
• 23.2. North America Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cardiogenomics Market

• 24.1. USA Cardiogenomics Market Overview
• 24.2. USA Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cardiogenomics Market

• 25.1. Canada Cardiogenomics Market Overview
• 25.2. Canada Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cardiogenomics Market

• 26.1. South America Cardiogenomics Market Overview
• 26.2. South America Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cardiogenomics Market

• 27.1. Brazil Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cardiogenomics Market

• 28.1. Middle East Cardiogenomics Market Overview
• 28.2. Middle East Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cardiogenomics Market

• 29.1. Africa Cardiogenomics Market Overview
• 29.2. Africa Cardiogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cardiogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cardiogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cardiogenomics Market Competitive Landscape And Company Profiles

• 30.1. Cardiogenomics Market Competitive Landscape
• 30.2. Cardiogenomics Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Laboratory Corporation of America Holdings (Labcorp) Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. QIAGEN N.V. Overview, Products and Services, Strategy and Financial Analysis

31. Cardiogenomics Market Other Major And Innovative Companies

• 31.1. Myriad Genetics Inc.
• 31.2. ARUP Laboratories
• 31.3. BGI Genomics Co. Ltd.
• 31.4. Invitae Corporation
• 31.5. GeneDx Inc.
• 31.6. Helix OpCo LLC
• 31.7. SOPHiA GENETICS SA
• 31.8. Baylor Genetics
• 31.9. Blueprint Genetics
• 31.10. Novogenia GmbH
• 31.11. Veritas Genetics
• 31.12. Dante Genomics
• 31.13. Gene by Gene Ltd.
• 31.14. GENinCode Plc.
• 31.15. UAB Cardiogenomics Clinic

32. Global Cardiogenomics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiogenomics Market

34. Recent Developments In The Cardiogenomics Market

35. Cardiogenomics Market High Potential Countries, Segments and Strategies

• 35.1 Cardiogenomics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cardiogenomics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cardiogenomics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer